steven shapiro

May 09, 2012: The FDA’s DMAA Gamble

By James J. Gormley Courtesy of the SupplySide Community On April 24th, the U.S. Food and Drug Administration (FDA) sent warning letters to 10 companies cautioning them, in the strictest possible terms, that their DMAA (1,3 Dimethylamylamine)-containing products may be considered new dietary ingredients for which notifications have not been submitted and, so, would be adulterated products in violation of…